Blog
  • Omnichannel
  • Oncology
  • Conferences
  • PERxCEPT
  • Ferma.AI
  • Launch Excellence
Vinny Valant

Vinny Valant

6 posts •
Being Heard During Treatment Decisions: Quantifying HCP-Patient Conversation Dynamics
Customer Engagement

Being Heard During Treatment Decisions: Quantifying HCP-Patient Conversation Dynamics

To understand the dynamics of HCP-patient communication, ZoomRx conducted an audit of 381 clinical conversations during which a treatment decision was made. These conversations covered a variety of therapeutic areas, including Central Nervous

  • Vinny Valant
    Vinny Valant
4 min read
Uncovering the True Impact of a Black Box Warning
Customer Engagement

Uncovering the True Impact of a Black Box Warning

ZoomRx’s HCP-Patient dialogue research helped brands understand how HCPs were messaging the safety profile of their JAK product based on clinical data. Access the insights in this case study.

  • Vinny Valant
    Vinny Valant
1 min read
Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue
Oncology

Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue

The prostate-specific antigen (PSA) score has become a critical post-diagnosis tool for oncologists as they discuss prostate cancer disease state with their patients along with their families and caregivers.Oncologist-patient relationships are based

  • Vinny Valant
    Vinny Valant
  • Kinga Zapert
    Kinga Zapert
3 min read
Exploring Factors Influencing Individualized Treatment: Breast Cancer
Customer Engagement

Exploring Factors Influencing Individualized Treatment: Breast Cancer

Oncologists often develop individualized treatment plans to ensure patients are receiving care tailored to their situation. Here are factors influencing their decisions.

  • Vinny Valant
    Vinny Valant
3 min read
A New Approach for Healthcare Dialogue Research
Customer Engagement

A New Approach for Healthcare Dialogue Research

Often, traditional research doesn't answer all questions pertaining to clinical treatment decisions. Here's ZoomRx's new approach to address such questions.

  • Vinny Valant
    Vinny Valant
2 min read
How MDs are discussing migraine treatment options with patients
Customer Engagement

How MDs are discussing migraine treatment options with patients

Since 2018, the migraine treatment landscape has changed dramatically, with two new approvals in the month of February alone (Vyepti, Nurtec ODT). In light of these developments, we were curious about how migraine

  • Vinny Valant
    Vinny Valant
2 min read

All rights reserved ZoomRx - 2020.   Privacy Policy


HOME
PERSPECTIVES
PANELISTS
CAREERS